Literature DB >> 20555362

Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies.

J Adélaïde, V Gelsi-Boyer, J Rocquain, N Carbuccia, D J Birnbaum, P Finetti, F Bertucci, M J Mozziconacci, N Vey, D Birnbaum, M Chaffanet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20555362     DOI： 10.1038/leu.2010.135

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b.

Authors:  Yoshihiro Kobashigawa; Akira Tomitaka; Hiroyuki Kumeta; Nobuo N Noda; Masaya Yamaguchi; Fuyuhiko Inagaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-07       Impact factor: 11.205

2.  A point mutation of zebrafish c-cbl gene in the ring finger domain produces a phenotype mimicking human myeloproliferative disease.

Authors:  X Peng; M Dong; L Ma; X-E Jia; J Mao; C Jin; Y Chen; L Gao; X Liu; K Ma; L Wang; T Du; Y Jin; Q Huang; K Li; L I Zon; T Liu; M Deng; Y Zhou; X Xi; Y Zhou; S Chen
Journal:  Leukemia       Date:  2015-06-24       Impact factor: 11.528

Review 3.  Myeloid malignancies: mutations, models and management.

Authors:  Anne Murati; Mandy Brecqueville; Raynier Devillier; Marie-Joelle Mozziconacci; Véronique Gelsi-Boyer; Daniel Birnbaum
Journal:  BMC Cancer       Date:  2012-07-23       Impact factor: 4.430

Review 4.  Mutations of c-Cbl in myeloid malignancies.

Authors:  Shulamit Katzav; M Lienhard Schmitz
Journal:  Oncotarget       Date:  2015-05-10

5.  Interpretable per case weighted ensemble method for cancer associations.

Authors:  Adrin Jalali; Nico Pfeifer
Journal:  BMC Genomics       Date:  2016-07-19       Impact factor: 3.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.